628
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Expression Profile of Atp-Binding Cassette Transporter Genes in Breast Carcinoma

, , , , , , , , , , & show all
Pages 515-529 | Published online: 05 Apr 2013

References

  • Ferlay J , ShinHR, BrayF, FormanD, MathersC, ParkinDM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int. J. Cancer.127 , 2893–2917 (2010).
  • Coughlin SS , EkwuemeDU. Breast cancer as a global health concern. Cancer Epidemiol.33 , 315–318 (2009).
  • Baguley BC . Multiple drug resistance mechanisms in cancer. Mol. Biotechnol.46 , 308–316 (2010).
  • Szakács G , PatersonJK, LudwigJA, Booth-GentheC, GottesmanMM. Targeting multidrug resistance in cancer. Nat. Rev. Drug Discov.5 , 219–234 (2006).
  • Klaassen CD , AleksunesLM. Xenobiotic, bile acid, and cholesterol transporters: function and regulation. Pharmacol. Rev.62 , 1–96 (2010).
  • Wolf SJ , BachtiarM, WangJ, SimTS, ChongSS, LeeCG. An update on ABCB1 pharmacogenetics: insights from a 3D model into the location and evolutionary conservation of residues corresponding to SNPs associated with drug pharmacokinetics. Pharmacogenomics J.11 , 315–325 (2011).
  • Burger H , FoekensJA, LookMP et al. RNA expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: correlation with chemotherapeutic response. Clin. Cancer Res. 9 , 827–836 (2003).
  • Atalay C , DemirkazikA, GunduzU. Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer. J. Chemother.20 , 734–739 (2008).
  • Larkin A , O‘DriscollL, KennedyS et al. Investigation of MRP-1 protein and MDR-1 P-glycoprotein expression in invasive breast cancer: a prognostic study. Int. J. Cancer 112 , 286–294 (2004).
  • Moureau-Zabotto L , RicciS, LefrancJP et al. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients. Br. J. Cancer 94 , 473–480 (2006).
  • Vaclavikova R , NordgardSH, AlnaesGIG et al. Single nucleotide polymorphisms in the multidrug resistance gene 1 (ABCB1): effects on its expression and clinicopathological characteristics in breast cancer patients. Pharmacogenet. Genomics 18 , 263–273 (2008).
  • Rudas M , FilipitsM, TaucherS et al. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy. Breast Cancer Res. Treat. 81 , 149–157 (2003).
  • Natarajan K , XieY, BaerMR, RossDD. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. Biochem. Pharmacol.83 , 1084–1103 (2012).
  • Park S , ShimizuC, ShimoyamaT et al. Gene expression profiling of ATP-binding cassette (ABC) transporters as a predictor of the pathologic response to neoadjuvant chemotherapy in breast cancer patients. Breast Cancer Res. Treat. 99 , 9–17 (2006).
  • Vaclavikova R , EhrlichovaM, HlavataI et al. Detection of frequent ABCB1 polymorphisms by high-resolution melting curve analysis and their effect on breast carcinoma prognosis. Clin. Chem. Lab. Med. 50 , 1999–2007 (2012).
  • Hubackova M , VaclavikovaR, EhrlichovaM et al. Association of superoxide dismutases and NAD(P)H oxidoreductases with prognosis of patients with breast carcinomas. Int. J. Cancer 130 , 338–348 (2012).
  • Hammond ME , HayesDF, DowsettM et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch. Pathol. Lab. Med. 134 , 907–922 (2010).
  • Slamon DJ , Leyland-JonesB, ShakS et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N. Engl. J. Med. 344 , 783–792 (2001).
  • Therasse P , ArbuckSG, EisenhauerEA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J. Natl Cancer Inst. 92 , 205–216 (2000).
  • Hlavata I , Mohelnikova-DuchonovaB, VaclavikovaR et al. The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27 , 187–196 (2012).
  • Mohelnikova-Duchonova B , OliveriusM, HonsovaE, SoucekP. Evaluation of reference genes and normalization strategy for quantitative real-time PCR in human pancreatic carcinoma. Dis. Markers32 , 203–130 (2012).
  • Bustin SA , BenesV, GarsonJA et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin. Chem. 55 , 611–622 (2009).
  • Vobořilová J , Němcová-FürstováV, NeubauerováJ et al. Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells. Invest. New Drugs 29(3) , 411–423 (2011).
  • Honorat M , MesnierA, VendrellJ et al. ABCC11 expression is regulated by estrogen in MCF7 cells, correlated with estrogen receptor α expression in postmenopausal breast tumors and overexpressed in tamoxifen-resistant breast cancer cells. Endocr. Relat. Cancer 15 , 125–138 (2008).
  • Xiang L , SuP, XiaS et al. ABCG2 is associated with HER-2 expression, lymph node metastasis and clinical stage in breast invasive ductal carcinoma. Diagn. Pathol. 6 , 90 (2011).
  • Bera TK , LeeS, SalvatoreG, LeeB, PastanI. MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol. Med.7 , 509–516 (2001).
  • Elston CW , EllisIO. Pathological prognostic factors in breast cancer I. The value of histological grade in breast cancer: experience from a large study with long-term follow up. Histopathology19 , 403–410 (1991).
  • Fasching PA , HeusingerK, HaberleL et al. Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment. BMC Cancer 11 , 486 (2011).
  • Charpin C , VielhP, DuffaudF et al. Quantitative immunocytochemical assays of P-glycoprotein in breast carcinomas: correlation to messenger RNA expression and to immunohistochemical prognostic indicators. J. Natl Cancer Inst. 86 , 1539–1545 (1994).
  • Rybárová S , HodorováI, HajdukováM et al. Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters. Neoplasma 53 , 128–135 (2006).
  • Zöchbauer-Müller S , FilipitsM, RudasM et al. P-glycoprotein and MRP1 expression in axillary lymph node metastases of breast cancer patients. Anticancer Res. 21 , 119–124 (2001).
  • McDonagh EM , Whirl-CarrilloM, GartenY, AltmanRB, KleinTE. From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource. Biomark. Med.5 , 795–806 (2011).
  • Thorn CF , OshiroC, MarshS et al. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet. Genomics 21 , 440–446 (2011).
  • Filipits M , PohlG, RudasM et al. Clinical role of multidrug resistance protein 1 expression in chemotherapy resistance in early-stage breast cancer: the Austrian Breast and Colorectal Cancer Study Group. J. Clin. Oncol. 23 , 1161–1168 (2005).
  • Reams RR , KalariKR, WangH, OdedinaFT, SolimanKF, YatesC. Detecting gene–gene interactions in prostate disease in African American men. Infect. Agent Cancer6 , S1–S10 (2011).
  • Yamamoto-Ibusuki M , YamamotoY, YamamotoS et al. Comparison of prognostic values between combined immunohistochemical score of estrogen receptor, progesterone receptor, human epidermal growth factor receptor 2, Ki-67 and the corresponding gene expression score in breast cancer. Mod. Pathol. 26 , 79–86 (2013).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.